Davis Hugh M.
SEC CIK 2045027 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Pres, COO, Dir | 45.4K | — | — | 2 | 2025-12-02 | 2026-02-03 |
Most active insiders at ACRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leonard Braden Michael | 10% | — | $1.36M |
| 2 | Kolbeck Roland Wilhelm | CSO | — | — |
| 3 | Hall Jesse Wayne | Chief Medical Off | — | — |
| 4 | Davis Hugh M. | Pres, COO, Dir | — | — |
| 5 | Balthaser Kevin | CFO | — | — |
| 6 | Loerop James | Chief Business Off | — | — |
| 7 | Humphries William D. | Dir | — | — |
| 8 | Molineaux Christopher P. | Dir | — | — |
| 9 | Walker Neal | CEO, Dir | — | — |
| 10 | Mehra Anand | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-05 | 2026-02-03 | ACRS | Aclaris Therapeutics, Inc. | Davis Hugh M. | Pres, COO, Dir | M - OptEx | — | +18.7K | 45.4K | +70% | — |
| D | 2025-12-04 | 2025-12-02 | ACRS | Aclaris Therapeutics, Inc. | Davis Hugh M. | Pres, COO, Dir | M - OptEx | — | +26.8K | 26.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations